Lena Hagman
Chief Operating Officer at XVIVO PERFUSION AB
Net worth: 51 437 $ as of 2024-03-30
Profile
Currently, Lena Hagman is Executive Vice President-Quality Regulatory at Getinge AB. Ms. Hagman previously occupied the position of Operations Director at Neoventa Medical AB.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
XVIVO PERFUSION AB
0.01% | 2022-12-30 | 2,000 ( 0.01% ) | 51 437 $ | 2024-03-30 |
Lena Hagman active positions
| Companies | Position | Start |
|---|---|---|
| XVIVO PERFUSION AB | Chief Operating Officer | 2022-11-30 |
Former positions of Lena Hagman
| Companies | Position | End |
|---|---|---|
| GETINGE AB | Compliance Officer | 2020-09-30 |
Neoventa Medical AB
 Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Chief Operating Officer | - |
Training of Lena Hagman
| Chalmers University of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GETINGE AB | Health Technology |
| XVIVO PERFUSION AB | Health Technology |
| Private companies | 1 |
|---|---|
Neoventa Medical AB
Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Health Technology |
- Stock Market
- Insiders
- Lena Hagman